HK1045942A1 - 結合(s)-2-(苄胺甲基)-2，3，8，9，-四氫-7h-1，4-二氧(2，3)吲-8-酮及精神抑制藥 - Google Patents

結合(s)-2-(苄胺甲基)-2，3，8，9，-四氫-7h-1，4-二氧(2，3)吲-8-酮及精神抑制藥

Info

Publication number
HK1045942A1
HK1045942A1 HK02107378.5A HK02107378A HK1045942A1 HK 1045942 A1 HK1045942 A1 HK 1045942A1 HK 02107378 A HK02107378 A HK 02107378A HK 1045942 A1 HK1045942 A1 HK 1045942A1
Authority
HK
Hong Kong
Prior art keywords
dioxino
neuroleptics
benzylamino
indol
tetrahydro
Prior art date
Application number
HK02107378.5A
Other languages
English (en)
Chinese (zh)
Inventor
Lovell Marquis Karen
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of HK1045942A1 publication Critical patent/HK1045942A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK02107378.5A 1999-12-10 2002-10-09 結合(s)-2-(苄胺甲基)-2，3，8，9，-四氫-7h-1，4-二氧(2，3)吲-8-酮及精神抑制藥 HK1045942A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45860799A 1999-12-10 1999-12-10
PCT/US2000/033060 WO2001041750A2 (en) 1999-12-10 2000-12-07 Combinations of (s)-2-(benzylamino-methyl)-2,3,8,9,-tetrahydro-7h-1,4-dioxino(2,3)-e indol-8-one and neuroleptics

Publications (1)

Publication Number Publication Date
HK1045942A1 true HK1045942A1 (zh) 2002-12-20

Family

ID=23821437

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02107378.5A HK1045942A1 (zh) 1999-12-10 2002-10-09 結合(s)-2-(苄胺甲基)-2，3，8，9，-四氫-7h-1，4-二氧(2，3)吲-8-酮及精神抑制藥

Country Status (20)

Country Link
EP (1) EP1235570A2 (ja)
JP (1) JP5557409B2 (ja)
KR (1) KR100772854B1 (ja)
CN (1) CN1230164C (ja)
AR (1) AR026756A1 (ja)
AU (1) AU784211B2 (ja)
BR (1) BR0016168A (ja)
CA (1) CA2396351C (ja)
CZ (1) CZ20021880A3 (ja)
EA (1) EA005002B1 (ja)
HK (1) HK1045942A1 (ja)
HU (1) HUP0203309A3 (ja)
IL (2) IL149669A0 (ja)
MX (1) MXPA02005649A (ja)
NO (1) NO20022739L (ja)
NZ (1) NZ519381A (ja)
PL (1) PL355292A1 (ja)
TW (1) TWI222864B (ja)
WO (1) WO2001041750A2 (ja)
ZA (1) ZA200205484B (ja)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GT200400218A (es) 2003-10-29 2005-06-06 Formulaciones de liberacion sostenida.
BRPI0608353A2 (pt) 2005-02-17 2009-12-01 Wyeth Corp derivados de indol, benzotiofeno, benzofurano e indeno cicloalquilfundidos
RU2481123C2 (ru) * 2008-02-13 2013-05-10 Таргасепт, Инк. Комбинация агонистов альфа 7 никотиновых рецепторов и антипсихотических средств

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2987484B2 (ja) * 1995-03-16 1999-12-06 大塚製薬 株式会社 カルボスチリル誘導体の製造方法
US5756532A (en) * 1995-11-06 1998-05-26 American Home Products Corporation Aminomethyl-2 3 8 9-tetrahydro-7H-1 4-dioxino 2 3-E!-indol-8-ones and derivatives
GB9627005D0 (en) * 1996-12-27 1997-02-12 Knoll Ag Therapeutic agents

Also Published As

Publication number Publication date
TWI222864B (en) 2004-11-01
MXPA02005649A (es) 2004-09-10
WO2001041750A3 (en) 2002-02-14
IL149669A (en) 2006-06-11
HUP0203309A2 (hu) 2003-01-28
PL355292A1 (en) 2004-04-05
AU1949001A (en) 2001-06-18
WO2001041750A2 (en) 2001-06-14
EA005002B1 (ru) 2004-10-28
EP1235570A2 (en) 2002-09-04
CZ20021880A3 (cs) 2002-08-14
NO20022739D0 (no) 2002-06-07
HUP0203309A3 (en) 2004-12-28
KR100772854B1 (ko) 2007-11-02
NO20022739L (no) 2002-06-07
ZA200205484B (en) 2003-12-31
JP5557409B2 (ja) 2014-07-23
NZ519381A (en) 2004-04-30
AU784211B2 (en) 2006-02-23
CA2396351C (en) 2009-11-10
CN1409633A (zh) 2003-04-09
IL149669A0 (en) 2002-11-10
CA2396351A1 (en) 2001-06-14
BR0016168A (pt) 2002-08-20
AR026756A1 (es) 2003-02-26
KR20030016207A (ko) 2003-02-26
CN1230164C (zh) 2005-12-07
JP2003516350A (ja) 2003-05-13
EA200200656A1 (ru) 2002-12-26

Similar Documents

Publication Publication Date Title
AU2485100A (en) Left and right side heart support
AU2001280070A1 (en) Electrostimulation system with electromyographic and visual biofeedback
HUP9903691A3 (en) Pesticidal karbanilide derivatives, preparation and use thereof
SI1019358T2 (sl) 3,3-diarilpropilamini, njihova uporaba in priprava
PL351250A1 (en) Antipicornaviral compounds, their preparation and use
ZA986421B (en) 2-[Pyrazolyl-and triazolyl-3'-oxymethylene]phenylisoxa zolones, -triazolones and - tetrazolones, their preparation and their use.
SI1043307T1 (en) 3-amino-3-arylpropan-1-ol-derivates, their preparation and their use
NZ330360A (en) 5'-deoxy-cytidine derivatives, their manufacture and use as antitumoral agents
AU3472799A (en) Dermatological formulations and methods
HUP0003811A3 (en) Oxyranyle-triazoline thiones, their preparation and their use as microbicides
EP0673999A3 (en) Trehalose phosphorylase and its production.
AU6351199A (en) Pectins and the preparation thereof
HUP0104510A3 (en) Benzofuran derivatives, their preparation and use
AU5446900A (en) Novel murine and human kinases
HK1045942A1 (zh) 結合(s)-2-(苄胺甲基)-2，3，8，9，-四氫-7h-1，4-二氧(2，3)吲-8-酮及精神抑制藥
AU2529799A (en) Benzofuran-4-carboxamides and their therapeutic use
AU4629399A (en) Substituted piperazones and their therapeutic uses
GB2332671B (en) Acetals, their preparation and their use
SI1043306T1 (en) 3-amino-3-arylpropan-1-ol-derivates, their preparation and use
HUP0102988A3 (en) Peroxides, their preparation process and use
ZA982950B (en) Stabilized human papillomavirus formulations
AU2227999A (en) Human ependymin
GB9807586D0 (en) Enzymes and their use
AU5623599A (en) Aza-cyclodepsipeptides and their use as antiparasitics
AU5472899A (en) Human angiopoietin-3